Initial 3-Weeks’ Apixaban Versus Dual-Antiplatelet Therapy (Clopidogrel and Aspirin) Followed by Clopidogrel Alone in High-Risk Patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): Study Protocol for a Randomized Controlled Trial

High Risk ◽

Antiplatelet Therapy ◽

Study Protocol ◽

Dual Antiplatelet Therapy ◽

Controlled Trial ◽

High Risk Patients ◽

Randomized Controlled ◽

Cerebrovascular Events ◽

Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-018-2761-x ◽

2018 ◽

Vol 19 (1) ◽

Cited By ~ 6

Author(s):

Friederike Schaub ◽

Robert Hoerster ◽

Petra Schiller ◽

Moritz Felsch ◽

Daria Kraus ◽

...

Keyword(s):

High Risk ◽

Retinal Detachment ◽

Study Protocol ◽

Proliferative Vitreoretinopathy ◽

Controlled Trial ◽

High Risk Patients ◽

Randomized Controlled ◽

Non-invasive programmed stimulation to identify high-risk patients with implanted cardioverter defibrillator (the NIPS-ICD study): study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-016-1170-2 ◽

2016 ◽

Vol 17 (1) ◽

Cited By ~ 1

Author(s):

Piotr Futyma ◽

Marian Futyma ◽

Piotr Kułakowski

Keyword(s):

High Risk ◽

Study Protocol ◽

Controlled Trial ◽

Cardioverter Defibrillator ◽

High Risk Patients ◽

Non Invasive ◽

Programmed Stimulation ◽

Randomized Controlled ◽

Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-018-2583-x ◽

2018 ◽

Vol 19 (1) ◽

Cited By ~ 4

Author(s):

Xavier J. N. M. Smeets ◽

◽

David W. da Costa ◽

Paul Fockens ◽

Chris J. J. Mulder ◽

...

Keyword(s):

High Risk ◽

Study Protocol ◽

Controlled Trial ◽

High Risk Patients ◽

Randomized Controlled ◽

Prophylactic penehyclidine inhalation for prevention of postoperative pulmonary complications in high-risk patients: study protocol of a randomized controlled trial

Trials ◽

10.1186/s13063-017-2315-7 ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 1

Author(s):

Ting Yan ◽

Xin-Quan Liang ◽

Tong Wang ◽

Wei-Ou Li ◽

Hui-Juan Li ◽

...

Keyword(s):

High Risk ◽

Study Protocol ◽

Controlled Trial ◽

Pulmonary Complications ◽

Postoperative Pulmonary Complications ◽

High Risk Patients ◽

Randomized Controlled ◽

Faculty Opinions recommendation of Efficacy of Atorvastatin in Prevention of Contrast-induced Nephropathy in High-risk Patients Undergoing Angiography: A Double-blind Randomized Controlled Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735810391.793560626 ◽

2019 ◽

Author(s):

Eric Hoste

Keyword(s):

High Risk ◽

Controlled Trial ◽

Contrast Induced Nephropathy ◽

Double Blind ◽

High Risk Patients ◽

Randomized Controlled ◽

Intraperitoneal Subdiaphragmatic Ropivacaine Instillation for Prevention of Shoulder Tip Pain After Laparoscopic Surgery in High-Risk Patients: A Randomized Controlled Trial

Journal of Gynecologic Surgery ◽

10.1089/gyn.2020.0169 ◽

2021 ◽

Author(s):

P.G. Paul ◽

Tasneem Saherwala ◽

Santwan Mehta ◽

Poulami Barma ◽

Sanghamitra Thakur ◽

...

Keyword(s):

Laparoscopic Surgery ◽

High Risk ◽

Controlled Trial ◽

High Risk Patients ◽

Randomized Controlled ◽

Cost-effectiveness of a technology-supported multimodal prehabilitation program in moderate-to-high risk patients undergoing lung cancer resection: randomized controlled trial protocol

BMC Health Services Research ◽

10.1186/s12913-020-05078-9 ◽

2020 ◽

Vol 20 (1) ◽

Author(s):

Anael Barberan-Garcia ◽

Ricard Navarro-Ripoll ◽

David Sánchez-Lorente ◽

Jorge Moisés-Lafuente ◽

Marc Boada ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

High Risk ◽

Controlled Trial ◽

Trial Protocol ◽

Cancer Resection ◽

High Risk Patients ◽

Randomized Controlled ◽

Sa1371 Periprocedural Fluid Type and Volume Reduce the Risk of Post-ERCP Pancreatitis in High Risk Patients: A Secondary Analysis of a Randomized Controlled Trial

Gastrointestinal Endoscopy ◽

10.1016/j.gie.2017.03.474 ◽

2017 ◽

Vol 85 (5) ◽

pp. AB213

Author(s):

Rupjyoti Talukdar ◽

Ayesha Kamal ◽

Venkata S. Akshintala ◽

Rajesh Goud ◽

Sundeep Lakhtakia ◽

...

Keyword(s):

High Risk ◽

Controlled Trial ◽

Secondary Analysis ◽

Fluid Type ◽

High Risk Patients ◽

Randomized Controlled ◽

Periprocedural Fluid Type and Volume Reduce the Risk of Post-ERCP Pancreatitis in High-Risk Patients: A Secondary Analysis of a Randomized Controlled Trial: 2017 ACG Governors Award for Excellence in Clinical Research

The American Journal of Gastroenterology ◽

10.14309/00000434-201710001-00006 ◽

2017 ◽

Vol 112 ◽

pp. S3

Author(s):

Venkata Akshintala ◽

Ayesha Kamal ◽

Rupjyoti Talukdar ◽

Rajesh Goud ◽

Mouen Khashab ◽

...

Keyword(s):

High Risk ◽

Clinical Research ◽

Controlled Trial ◽

Secondary Analysis ◽

Fluid Type ◽

High Risk Patients ◽

Randomized Controlled ◽

Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy

American Heart Journal ◽

10.1016/j.ahj.2019.04.017 ◽

2019 ◽

Vol 214 ◽

pp. 134-141 ◽

Cited By ~ 16

Author(s):

Elvin Kedhi ◽

Azeem Latib ◽

Alexandre Abizaid ◽

David Kandzari ◽

Ajay J. Kirtane ◽

...

Keyword(s):

Randomized Trial ◽

Antiplatelet Therapy ◽

Stent Placement ◽

Dual Antiplatelet Therapy ◽

Controlled Trial ◽

Bleeding Risk ◽

Randomized Controlled ◽

Risk Patients ◽

High Bleeding Risk